GTSE1 expression levels are related to OS and disease-free survival, and furthermore, could be used as a novel biomarker for patient prognosis and as a new therapeutic target for ccRCC [144]. This evidence concerns the gene GTSE1 and nonpapillary renal cell carcinoma.